R94M (p.Arg94Met) variant of ABL2 (Tyrosine-protein kinase ABL2)
R94M (p.Arg94Met) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
R94M (p.Arg94Met) variant details
- p.Arg94Met
- NCI-TCGA Cosmic COSV1007
- cosmic curated COSV10077
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.